Le Sueur man charged with sixth DWI after ATV crash

Kristine Goodrich, The Free Press, Mankato, Minn.
·1 min read

Apr. 7—LE SUEUR — A repeat drunken driver crashed an ATV into a vehicle, walked home injured and then resisted arrest in Le Sueur, charges say.

Joshua David Throldahl, 31, of Le Sueur, was charged with felony DWI Tuesday in Le Sueur County District Court. He also is charged with gross misdemeanor driving after license cancellation, misdemeanor failing to stop after a crash and misdemeanor obstructing the legal process.

According to the court complaint:

A witness reported a man crashed an ATV into the back of a vehicle on Swan Street Sunday night. The man reportedly staggered and lay down in the road for a few minutes before walking away.

A woman waved down officers outside Throldahl's residence a few blocks away. She said she had locked Throldahl out of the house after he left the family Easter gathering to go out drinking.

The woman said Throldahl returned home a few minutes prior, forced open the door and pushed her.

Officers found Throldahl asleep inside the residence with bleeding injuries to his head, shoulder, ankle and arms. He smelled of alcohol, yelled at officers and had slurred speech.

Throldahl resisted arrest but later agreed to go to Ridgeview Le Sueur Medical Center. He was transferred to Hennepin County Medical Center.

He refused to give a blood or urine sample to test his alcohol concentration. He swore at an officer and said: "I refuse to be entrapped by your society."

Throldahl has six prior DWI convictions and is on probation for the two most recent offenses in 2013.

Recommended Stories

  • Covid: Shed and garage offices pose insurance risk

    Plans to convert sheds, garages and extensions in order to work from home can leave some uninsured.

  • Boohoo: Price differences for same clothes 'a genuine mistake'

    Boohoo says it had not realised identical clothing was being sold at different prices across its brands.

  • GEO Group stock drops after high dividend suspended, REIT structure being evaluated

    Shares of GEO Group Inc. sank 3.5% in premarket trading Wednesday, after the real estate investment trust said it has immediately suspended its dividend, and will evaluate its structure as a REIT. The company said it plans to maximize the use of cash flows to repay debt and internally fund growth. The company last paid a quarterly dividend of 25 cents a share in January. Based on Tuesday's stock closing price of $7.80, the annual dividend rate had implied a dividend yield of 12.82%, compared with the yield on the SPDR Real Estate Select Sector ETF of 3.29% and the implied yield for the S&P 500 of 1.42%. "The board expects to conclude its evaluation in the fourth quarter of 2021, and should the Board determine not to change its current intent to maintain GEO's REIT status, an additional dividend payment may be required before year-end in order to meet the minimum REIT distribution requirements under the Code," the company said in a statement. The stock has tumbled 34.1% over the past 12 months, while the real estate ETF has climbed 28.6% and the S&P 500 has run up 53.2%.

  • Twilio (TWLO) Stock Sinks As Market Gains: What You Should Know

    Twilio (TWLO) closed the most recent trading day at $353.11, moving -1.24% from the previous trading session.

  • IBM (IBM) Outpaces Stock Market Gains: What You Should Know

    IBM (IBM) closed the most recent trading day at $134.93, moving +0.53% from the previous trading session.

  • Lockheed Martin (LMT) Outpaces Stock Market Gains: What You Should Know

    Lockheed Martin (LMT) closed the most recent trading day at $380.19, moving +0.32% from the previous trading session.

  • Frank Martin’s Gamecocks land second transfer this week

    The Gamecocks have now added two transfers this offseason while watching four players from last year’s team enter the portal.

  • Biden breaks with Trump and says he'll stick up for Federal Reserve's independence

    While he was in office, Trump pressured Fed Chair Powell against raising interest rates - the central bank traditionally operates independently.

  • Harry and Meghan's production company's first Netflix series pays tribute to the prince's royal roots

    Meghan Markle and Prince Harry's production company will release its first docuseries with Netflix next spring. And Harry will appear on camera.

  • Is Sorrento Stock a Buy Following ACEA Acquisition? Analyst Weighs In

    Sorrento (SRNE) is not a company to rest on its laurels, particularly on the acquisition front. There have been several additions to the biotech’s ever-expanding pipeline over the past few months, and April is proving no different. Earlier this week, Sorrento announced it is acquiring late-stage oncology company ACEA Therapeutics, in an all-stock deal worth $38 million. ACEA equity holders could also be eligible for milestone payments up to $450 million and 5-10% royalties from annual net sales. The merger is anticipated to close sometime in the second quarter. So, what does ACEA bring to the table? The company’s principal assets include AC0058, a next generation BTK inhibitor, currently in a U.S. Phase 1b trial for Lupus patients, and pre-clinical-stage candidate AC0939, a next generation FLT-3 inhibitor. ACEA also comes with a substantial proprietary library of small molecules (more than 1,000,000 compounds). These could potentially be applied to several human disease indications, such as non-small cell lung cancer (NSCLC), B cell lymphomas, systemic lupus, rheumatoid arthritis, multiple sclerosis and viral infections. However, for Dawson James analyst Jason Kolbert, the “gem” in the portfolio is late clinical-stage drug Abivertinib, an oral, next-gen, dual EGFR mutant and BTK inhibitor (BTKi). “Abivertinib has the potential to improve outcomes in resistant prostate cancer, systemic lupus erythematosus, and various B cell lymphomas in addition to NSCLC, an indication for which a registrational/Phase 3 trial has been completed. It is currently being studied as a Phase 2 treatment for COVID-19-induced respiratory compromise in the US and Brazil,” the analyst noted. The biotech will also get its hands on ACEA’s state-of-the-art cGMP facility situated in Quzhou, China. The facility is on a 23-acre campus with five buildings. In many ways, Kolbert says, ACEA resembles BeiGene Pharma, which today boasts a market cap of $32 billion. All in all, Kolbert rates SRNE shares a Buy along with a $19 price target. This figure implies 12-month gains of a strong 177%. (To watch Kolbert’s track record, click here) According to Holbert’s colleagues, his forecast is rather reserved. Going by the $28 average price target, the shares will appreciate by 269% over the coming months. All 4 analysts who have recently reviewed Sorrento, rate the stock a Buy, naturally culminating in a Strong Buy consensus rating. (See SRNE stock analysis on TipRanks) To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

  • New Jersey family temporarily kicked off Spirit flight after toddler eats without mask

    A family says it was kicked off because a toddler was unmasked while eating while Spirit says it was the parents who violated the federal mask order.

  • FTL cops, mistaking Star Trek memorabilia for weaponry, used excessive force, suit says

    A lawsuit filed by two brothers claims Fort Lauderdale and its police department violated their civil rights and conceals officer misconduct

  • Son of slain jeweler pleads guilty, sentenced to 35 years

    The son of a slain Texas jeweler was sentenced to 35 years in prison Wednesday after admitting he hired someone to kill his father. Nicolas Patrick Shaughnessy, 22, entered a guilty plea to a murder charge during a virtual court hearing. “It would be our hope that you are never released from prison,” the family wrote.

  • A huge sawfish was discovered dead in the Lower Keys, police said.

    A large sawfish — a federally protected species — was found dead Tuesday afternoon near a popular boating spot in the Lower Keys, police said.

  • LA sheriff says Tiger Woods was driving more than 80 mph before crash

    The Los Angeles County sheriff said Wednesday that high speed caused Tiger Woods' crash. The golfer was going more than 80 mph, nearly twice the speed limit when he crashed in Southern California, officials said.

  • UK PM urges calm as Belfast protesters hijack bus, attack police

    BELFAST (Reuters) -Crowds of youths in a pro-British area of Belfast set a hijacked bus on fire and attacked police with stones in the latest of a series of nightly outbreaks of violence that began last week. British Prime Minister Boris Johnson said he was "deeply concerned" by the violence, which has injured dozens of police officers in recent days as protesters burned cars and hurled petrol bombs at police. The violence comes amid growing frustration among many in the pro-British unionist community at new trade barriers between Northern Ireland and the rest of the United Kingdom that resulted from Britain's exit from the European Union.

  • Taiwan warns it will fight to 'the very last day' if attacked as China steps up its military activity nearby

    The Chinese military sent an aircraft carrier group led by the Liaoning to drill in waters near Taiwan on Monday. It also sent military aircraft.

  • Kehlani says that being 'straight-presenting' has afforded her 'a lot of privilege' as a queer person

    The singer said she's had a different experience than other queer artists who haven't been able to hide their identities as easily as her.

  • Benefits of AstraZeneca vaccine outweigh risks: Swedish Medical Products Agency

    The Swedish Medical Products Agency said on Wednesday the benefits of the AstraZeneca COVID-19 vaccine outweighed the risks after the EU drug regulator said it had found a possible link between the shot and rare blood clots. Sweden paused the use of the AstraZeneca vaccine in March after reports of rare but serious blood clots among people vaccinated with the AstraZeneca shot. "We stand behind this conclusion, that the benefits outweigh the risks," Ulla Wandel Liminga at the Medical Products Agency told a news conference.

  • After sex crime with inmate, Columbia man is arrested and fired, prison officials say

    The Columbia man was charged with first-degree sexual misconduct with an inmate, and faces a decade behind bars if convicted.